Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00000151
NCT00000151
View on ClinicalTrials.gov
Early Treatment Diabetic Retinopathy Study (ETDRS)
PHASE3
Completed
INTERVENTIONAL
Timeline
Start Date
December 31, 1979
Conditions
Blindness
Diabetic Retinopathy
Interventions
DRUG
Aspirin
PROCEDURE
Argon Laser Photocoagulation
All Listed Sponsors
lead
National Eye Institute (NEI)
NIH
NCT00000151 - Early Treatment Diabetic Retinopathy Study (ETDRS) | Biotech Hunter | Biotech Hunter